HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Klaus Busam Selected Research
Klaus Busam Research Topics
Disease
30
Neoplasms (Cancer)
10/2023 - 01/2002
30
Melanoma (Melanoma, Malignant)
03/2023 - 12/2002
3
Neoplasm Metastasis (Metastasis)
11/2012 - 10/2007
2
Nevus (Nevi)
01/2022 - 07/2012
2
Lymphatic Metastasis
01/2017 - 01/2004
1
Insulinoma
10/2023
1
Sinus Histiocytosis (Rosai-Dorfman Disease)
08/2019
1
Vascular Malformations
01/2019
1
Hemangioma (Angioma)
01/2019
1
Lymphoma (Lymphomas)
07/2017
1
Mycosis Fungoides
06/2016
1
Bullous Pemphigoid (Pemphigoid)
01/2016
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2016
1
Glioma (Gliomas)
01/2016
1
Carcinogenesis
07/2012
1
Infections
03/2012
1
Hepatomegaly
12/2011
1
Uveal melanoma
12/2011
1
Sarcoma (Soft Tissue Sarcoma)
05/2008
1
Neuroendocrine Carcinoma
02/2008
1
Testicular Neoplasms (Testicular Cancer)
07/2007
1
Cutaneous Malignant Melanoma
03/2007
1
Skin Neoplasms (Skin Cancer)
09/2006
1
Exanthema (Rash)
08/2006
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2006
1
Vascular Skin Diseases
08/2006
1
Porokeratosis (Palmoplantar Porokeratosis)
04/2006
1
Carcinoma (Carcinomatosis)
10/2003
Drug/Important Bio-Agent (IBA)
12
Proteins (Proteins, Gene)
FDA Link
10/2023 - 12/2002
6
DNA (Deoxyribonucleic Acid)
IBA
09/2013 - 01/2002
4
Paraffin
IBA
01/2019 - 09/2013
4
Formaldehyde (Formol)
FDA Link
01/2019 - 09/2013
3
Calcitriol Receptors (Calcitriol Receptor)
IBA
01/2018 - 01/2012
3
Antigens
IBA
01/2017 - 07/2007
2
relatlimab
IBA
03/2023 - 11/2022
2
Nivolumab
IBA
03/2023 - 11/2022
2
Codon (Codons)
IBA
01/2019 - 05/2012
2
Ipilimumab
IBA
09/2013 - 08/2011
1
Progesterone Receptors (Progesterone Receptor)
IBA
10/2023
1
Estrogen Receptors
IBA
10/2023
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2023
1
Messenger RNA (mRNA)
IBA
12/2021
1
Bexarotene (LGD1069)
FDA Link
08/2019
1
Vitamin D
FDA Link
Generic
01/2018
1
Rituximab (Mabthera)
FDA Link
07/2017
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
06/2016
1
Autoantibodies
IBA
01/2016
1
Monoclonal Antibodies
IBA
01/2016
1
Complement System Proteins (Complement)
IBA
01/2016
1
Microphthalmia-Associated Transcription Factor
IBA
05/2014
1
1-methyl-1-piperidinomethane sulfonate
IBA
08/2013
1
Chromatin
IBA
02/2013
1
Collagen
IBA
02/2013
1
Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)
IBA
02/2013
1
MicroRNAs (MicroRNA)
IBA
11/2012
1
Nucleic Acids
IBA
11/2012
1
Apolipoproteins E (ApoE)
IBA
11/2012
1
Cyclin D1
IBA
07/2012
1
Alkaline Phosphatase
IBA
12/2011
1
Transaminases (Aminotransferases)
IBA
12/2011
1
Monophenol Monooxygenase (Tyrosinase)
IBA
08/2011
1
MART-1 Antigen
IBA
08/2011
1
Antibodies
IBA
08/2011
1
Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)
IBA
12/2010
1
Mitogen-Activated Protein Kinases
IBA
12/2010
1
Indicators and Reagents (Reagents)
IBA
11/2010
1
Cyclin-Dependent Kinase Inhibitor p16
IBA
06/2008
1
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
06/2008
1
Methyltransferases
IBA
05/2008
1
Temozolomide (Temodar)
FDA Link
Generic
05/2008
1
Angiogenesis Inhibitors
IBA
05/2008
1
Chromogranins
IBA
02/2008
1
Synaptophysin
IBA
02/2008
1
Matrix Metalloproteinases (MMPs)
IBA
10/2007
1
Peptides (Polypeptides)
IBA
07/2007
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
05/2007
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
03/2007
1
Type 1 Melanocortin Receptor
IBA
09/2006
1
Imatinib Mesylate (Gleevec)
FDA Link
09/2006
1
Phosphotransferases (Kinase)
IBA
09/2006
1
Mitogens
IBA
09/2006
1
Biomarkers (Surrogate Marker)
IBA
08/2006
1
Bortezomib (Velcade)
FDA Link
08/2006
1
Proteasome Inhibitors
IBA
08/2006
1
lysyllysine (Lys-Lys)
IBA
03/2006
1
aspartyl-aspartic acid (Asp-Asp)
IBA
03/2006
1
ORALIT (ORS)
IBA
03/2006
1
ethyl 4(5)-imidazolecarboxylate
IBA
03/2006
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
12/2003
1
Coloring Agents (Dyes)
IBA
10/2003
1
iso-sulfan blue (Lymphazurin)
FDA Link
Generic
10/2003
1
RNA (Ribonucleic Acid)
IBA
05/2003
Therapy/Procedure
6
Therapeutics
09/2013 - 01/2002
3
Lymph Node Excision (Lymph Node Dissection)
01/2009 - 01/2004
2
Immunotherapy
09/2013 - 07/2007
2
Radiotherapy
01/2004 - 10/2003
1
Mohs Surgery (Mohs' Micrographic Surgery)
11/2019
1
Ligation
06/2008
1
Transplantation
04/2006
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2006